| Symbol | Name | Time | Trade | Change | % Chg | Volume | Intraday | Related Info |
|---|---|---|---|---|---|---|---|---|
| ACUS | Acusphere, Inc. | 17 Nov | 0.51 | 0.00 $ | 0.00% | 0 | Chart, more... | |
| GENZ | Genzyme Corporation | 6:51pm | 49.92 | 1,470,751 | Chart, more... | |||
| GTCB | GTC Biotherapeutics Inc | 6:49pm | 1.02 | 0.00 $ | 0.00% | 6,856 | Chart, more... | |
| IMCL | ImClone Systems Incorporated | 17 Nov | 69.67 | 0.00 $ | 0.00% | 0 | Chart, more... | |
| TRI.TO | THOMSON REUTERS CORP | 6:51pm | 32.95 | 394,921 | Chart, more... |
| Tue 12:55pm | TRI.TO | Domestic demand, commods to drive emerging sharesReuters MOLT |
| Tue 12:48pm | GENZ | UPDATE 1-Shire asks EU for Gaucher drug approvalOther |
| Sun, 22 Nov | TRI.TO | Chi-X leaves upstart label behind [at Financial Times]FT Times |
| Sat, 21 Nov | TRI.TO | Rio's Cloud Peak down in debutReuters MOLT |
| Fri, 20 Nov | TRI.TO | Strong finale to year possible [at Financial Times]FT Times |
| Fri, 20 Nov | TRI.TO | WRAPUP 3-Rio's Cloud Peak down in debut, others fare betterOther |
| Fri, 20 Nov | IMCL | Pinstripe and prison stripe [at Financial Times]FT Times |
| Tue, 17 Nov | GENZ | Footsie drifts from high [at Financial Times]FT Times |
| Tue, 17 Nov | GENZ | US midday: Shares remain down but stage recoveryShareCast |
| Mon, 16 Nov | GENZ | FTSE 100 extends year-high [at Financial Times]FT Times |
| Mon, 16 Nov | GENZ | UPDATE 2-Genzyme's Pompe drug rejected--new production woesOther |
| Wed, 11 Nov | IMCL | Marcial: Is Eli Lilly Ripe for a Rebound? [at BusinessWeek Online]Business Week |